Prothena Corporation plc (PRTA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 21.29 |
| Open | 21.25 |
| Bid | 20.52 x 200 |
| Ask | 20.60 x 100 |
| Day's Range | 20.44 - 21.69 |
| 52 Week Range | 20.42 - 79.65 |
| Volume | |
| Avg. Volume | 663,598 |
| Market Cap | 1.104B |
| Beta (5Y Monthly) | 0.24 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Investor's Business Daily
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
The Alzheimer's treatment space is heating up — and could soon leave Eli Lilly's embattled drug, donanemab, in the dust, experts say.
- Zacks
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
Per Biogen (BIIB)/Eisai, the delay in CHMP recommendation for lecanemab is entirely related to procedural reasons at the EMA and is not related to the companies' regulatory filing.
- Simply Wall St.
Prothena Full Year 2023 Earnings: Beats Expectations
Prothena ( NASDAQ:PRTA ) Full Year 2023 Results Key Financial Results Revenue: US$91.4m (up 70% from FY 2022). Net...
© 2024 Yahoo. All rights reserved.